Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Lung Cancer (Amsterdam, Netherlands)|June 2, 2026
Comparative efficacy of tarlatamab and second-line therapies in extensive-stage small cell lung cancer: A network meta-analysisJessie Wang, Rumbidzai Takundwa, Hongbo Yang, et al.Scientific Reports|July 7, 2025
Head and neck tumor organoid grown under simplified media conditions model tumor biology and chemoradiation responsesWeilin Li, Michiya Nishino, Eric Reed, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2017
Continuum of Care for Hepatitis C Virus Among Patients Diagnosed in the Emergency Department SettingErik S Anderson, James W Galbraith, Laura J Deering, et al.MMWR. Morbidity and Mortality Weekly Report|May 15, 2020
High Prevalence of Hepatitis C Infection Among Adult Patients at Four Urban Emergency Departments - Birmingham, Oakland, Baltimore, and Boston, 2015-2017James W Galbraith, Erik S Anderson, Yu-Hsiang Hsieh, et al.BMJ Open|June 3, 2026
Emergency Department-initiated standard versus high-dose buprenorphine induction (ENVISION): a randomised clinical trial protocolKathryn Hawk, Andrew Herring, Marek Chawarski, et al.Clinical Epidemiology|December 26, 2025
A Multi-Country Study of the Clinical Course of Extensive-Stage Small Cell Lung Cancer: A Six-Study Analysis of Real-World Treatment Patterns and OutcomesXerxes Pundole, Diana Younan, Cathy W Critchlow, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 11, 2022
Clinical Utility of the Signal-to-Cutoff Ratio of Reactive HIV Antigen/Antibody Screening Tests in Guiding Emergency Physician ManagementDouglas A E White, Erik S Anderson, Kellie Basham, et al.Plos One|April 13, 2022
Facemasks: Perceptions and use in an ED population during COVID-19Vidya Eswaran, Anna Marie Chang, R Gentry Wilkerson, et al.Cell Metabolism|May 28, 2013
EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancerIvan Babic, Erik S Anderson, Kazuhiro Tanaka, et al.Future Oncology (London, England)|November 12, 2024
Plain language summary: tarlatamab for patients with previously treated small cell lung cancerMyung-Ju Ahn, Byoung Chul Cho, Enriqueta Felip, et al.Pageof 6